ArticleJournal of the National Cancer Institute2025

Strength of evidence underlying the CMS-FDA parallel review of comprehensive genomic profiling tests in the cancer setting.

Sydnie Stackland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.